Technology Networks

CRISPR Study Reveals Gene Linking Down Syndrome to Heart Disease

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
Technology Networks

Unlocking the Power of Oligonucleotides: From Rare Disease Therapeutics to CRISPR and Beyond

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

Researchers make incredible breakthrough that could help us keep food fresh longer: 'Paradigm-changing'

Ultimately, the collaboration is focused on speeding up progress toward a safer and more resilient food system. As Corbion's ...

TCCI Pledges $1 Billion for AI Research at First Science Symposium in San Francisco

The inaugural TCCI AI-Driven Science Symposium was held in San Francisco from Monday to Tuesday, bringing together three ...
Zacks Investment Research on MSN

CRISPR Therapeutics AG (CRSP) Stock Moves -2.51%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $62.56, moving -2.51% from the previous trading session. Elsewhere, the Dow saw a downswing of 0.16%, while the tech-heavy Nasdaq ...
The Manila Times

ICHORtec and Johns Hopkins University Expand Collaboration to Enhance CRISPR Gene Editing Specificity Using Quantum FMB® Technology

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

Crispr gave humans the power to remake ourselves. What will we do with it?

On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...

Human organ chip technology sets stage for pan-influenza A CRISPR RNA therapies

The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.

A Look at CRISPR Therapeutics’s Valuation Following New CTX460 Gene Editing Breakthrough Data

CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...

Researchers make breakthrough in effort to save chocolate industry from looming threat: 'Offers hope'

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.
Zacks Investment Research on MSN

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Intellia pauses gene therapy trials after patient suffers liver injury, shares slide

Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said on Monday, ...